| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.0000136814.87170.B1 |
| P698 | PubMed publication ID | 15249501 |
| P50 | author | Luis M Blanco-Colio | Q55542660 |
| Jose L Martín-Ventura | Q62131494 | ||
| Jesus Egido | Q120487826 | ||
| P2093 | author name string | Jean-Baptiste Michel | |
| Ole N Jensen | |||
| Olivier Meilhac | |||
| Fernando Vivanco | |||
| Anne Leclercq | |||
| Luis Miguel Blanco-Colio | |||
| José Tuñón | |||
| Jose Luis Martin-Ventura | |||
| Sergio Hernandez-Merida | |||
| Mari Carmen Duran | |||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 2216-2219 | |
| P577 | publication date | 2004-07-12 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis | |
| P478 | volume | 110 |
| Q33361805 | A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries |
| Q33797542 | A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima. |
| Q81224733 | Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome |
| Q38967410 | Applications of Two-Dimensional Electrophoresis Technology to the Study of Atherosclerosis |
| Q37500635 | Biomarkers in cardiovascular medicine |
| Q36775610 | Cardiovascular proteomics: past, present, and future |
| Q34144310 | Carotid atherosclerotic plaques: proteomics study after a low-abundance protein enrichment step |
| Q57892523 | Changes in Plasma Level of Heat Shock Protein 27 After Acute Coronary Syndrome |
| Q34586387 | Chronic over-expression of heat shock protein 27 attenuates atherogenesis and enhances plaque remodeling: a combined histological and mechanical assessment of aortic lesions |
| Q42346812 | Cooling the fire of atherosclerosis with heat shock protein 27. |
| Q34216817 | Development of subtype-selective oestrogen receptor-based therapeutics. |
| Q45102946 | Early detection of acute coronary syndromes and risk stratification by multimarker analysis |
| Q45922502 | Expression of heat shock proteins and nitrotyrosine in small arteries from patients with coronary heart disease. |
| Q36428109 | Extracellular HSP27 acts as a signaling molecule to activate NF-κB in macrophages. |
| Q26738276 | Extracellular Release and Signaling by Heat Shock Protein 27: Role in Modifying Vascular Inflammation |
| Q47584707 | Extracellular small heat shock proteins: exosomal biogenesis and function |
| Q40845747 | HSP27 Inhibits Homocysteine-Induced Endothelial Apoptosis by Modulation of ROS Production and Mitochondrial Caspase-Dependent Apoptotic Pathway |
| Q47294278 | Heat Shock Proteins in Vascular Diabetic Complications: Review and Future Perspective |
| Q37007991 | Heat shock factor-1 knockout enhances cholesterol 7α-hydroxylase (CYP7A1) and multidrug transporter (MDR1) gene expressions to attenuate atherosclerosis |
| Q36298929 | Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target |
| Q44224685 | Heat shock protein 27 expression is spatially distributed in human placenta and selectively regulated during preeclampsia |
| Q57790882 | Heat shock protein 27 is associated with better nerve function and fewer signs of neuropathy |
| Q36550110 | Heat shock protein 27: its potential role in vascular disease |
| Q53702607 | Heat shock protein-27 and sex-selective regulation of muscarinic and proteinase-activated receptor 2-mediated vasodilatation: differential sensitivity to endothelial NOS inhibition. |
| Q34182265 | Heat shock protein-27 delays acute rejection after cardiac transplantation: an experimental model |
| Q36488793 | Heat shock proteins: pathogenic role in atherosclerosis and potential therapeutic implications |
| Q47114721 | Hsp-27 levels and thrombus burden relate to clinical outcomes in patients with ST-segment elevation myocardial infarction |
| Q41263014 | Identification of a protective role for protein phosphatase 1cgamma1 against oxidative stress-induced vascular smooth muscle cell apoptosis |
| Q38756916 | Identifying new Risk Markers and Potential Targets: The Value of the Proteome |
| Q92327050 | IgG Anti-High Density Lipoprotein Antibodies Are Elevated in Abdominal Aortic Aneurysm and Associated with Lipid Profile and Clinical Features |
| Q52885724 | Increased expression of phosphorylated forms of heat-shock protein-27 and p38MAPK in macrophage-rich regions of fibro-fatty atherosclerotic lesions in the rabbit. |
| Q37852494 | Intraplaque haemorrhages as the trigger of plaque vulnerability |
| Q37160916 | Modification of the secretion pattern of proteases, inflammatory mediators, and extracellular matrix proteins by human aortic valve is key in severe aortic stenosis |
| Q35964911 | Molecular chaperones and heat shock proteins in atherosclerosis |
| Q28088373 | Novel methodologies for biomarker discovery in atherosclerosis |
| Q35040467 | Novel network biomarkers profile based coronary artery disease risk stratification in Asian Indians |
| Q37715696 | Pediatric Sepsis - Part V: Extracellular Heat Shock Proteins: Alarmins for the Host Immune System |
| Q34446395 | Plasma heat shock protein 27 is associated with coronary artery disease, abdominal aortic aneurysm and peripheral artery disease. |
| Q27000682 | Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overview |
| Q91603392 | Prophylactic salpingo-oophorectomy & surgical menopause for inherited risks of cancer: the need to identify biomarkers to assess the theoretical risk of premature coronary artery disease |
| Q33624625 | Protective effect of phosphorylated Hsp27 in coronary arteries through actin stabilization |
| Q37207340 | Proteomic Biomarkers of Atherosclerosis |
| Q33337003 | Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension |
| Q37738351 | Proteomic and metabolomic profiles in atherothrombotic vascular disease |
| Q51615648 | Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential. |
| Q36787244 | Proteomics in atherothrombosis: a future perspective |
| Q34975175 | Proteomics of acute coronary syndromes |
| Q38106664 | Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis |
| Q35854596 | Proteotoxic stress and circulating cell stress proteins in the cardiovascular diseases. |
| Q38034137 | Recent advances in proteomic technologies applied to cardiovascular disease. |
| Q31131103 | Retracted: Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor |
| Q90163791 | Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion |
| Q39802639 | Safety, tolerability, pharmacokinetics, and pharmacodynamics of losmapimod in healthy Japanese volunteers |
| Q36756496 | Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy |
| Q60044374 | Serum heat shock protein 27 levels predict cardiac mortality in hemodialysis patients |
| Q64239461 | Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women |
| Q42324363 | Simvastatin and losartan differentially and synergistically inhibit atherosclerosis in apolipoprotein e(-/-) mice |
| Q39078958 | Small heat shock proteins in ageing and age-related diseases |
| Q24641828 | Small heat shock proteins in smooth muscle |
| Q38161316 | Systems biology of human atherosclerosis |
| Q51066680 | The Potential Functions of Small Heat Shock Proteins in the Uterine Musculature during Pregnancy. |
| Q50880007 | The atheroma plaque secretome stimulates the mobilization of endothelial progenitor cells ex vivo. |
| Q37404662 | The role of estrogen receptor subtypes for vascular maintenance. |
| Q38229874 | The role of heat shock proteins in atherosclerosis |
| Q37579906 | Tissue proteomics in atherosclerosis: elucidating the molecular mechanisms of cardiovascular diseases. |
| Q38552059 | Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform. |
| Q37610301 | Vascular proteomics, a translational approach: from traditional to novel proteomic techniques. |
Search more.